<SEC-DOCUMENT>0001295345-17-000246.txt : 20170814
<SEC-HEADER>0001295345-17-000246.hdr.sgml : 20170814
<ACCEPTANCE-DATETIME>20170814084652
ACCESSION NUMBER:		0001295345-17-000246
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170630
FILED AS OF DATE:		20170814
DATE AS OF CHANGE:		20170814
EFFECTIVENESS DATE:		20170814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emerald Medical Applications Corp.
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		171027429

	BUSINESS ADDRESS:	
		STREET 1:		7 IMBER STREET
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951141
		BUSINESS PHONE:		97237444505

	MAIL ADDRESS:	
		STREET 1:		7 IMBER STREET
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZAXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19950916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFERGENE CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>mrla_nt.htm
<DESCRIPTION>LATE NOTIFICATION
<TEXT>
<html>
<body>
<b><font SIZE="5">

<p ALIGN="CENTER"></font><font size="4">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION</font></b></p>

<p ALIGN="CENTER"><font size="4">Washington, D.C. 20549</font></p>

<p ALIGN="CENTER">&nbsp;</p>

<p ALIGN="CENTER"><font SIZE="5"><strong><u>EMERALD MEDICAL APPLICATIONS CORP.</u><br>
</strong></font><font size="1">(Full Name of Registrant)</font></p>

<p ALIGN="CENTER"><font size="4">FORM 12b-25</font></p>

<p ALIGN="CENTER">NOTIFICATION OF LATE FILING</p>

<p ALIGN="CENTER"><font SIZE="2">SEC FILE NUMBER: [0-15476]</font></p>

<p><font SIZE="2">(Check One): [&nbsp; ]Form 10-K [ ] Form 20-F [ ]Form
11-K [X] Form 10Q [&nbsp; ] Form N-SAR [ ]</font></p>

<p><font SIZE="2">For Period Ended: <br>
[ ] Transition Report on Form 10-K<br>
[ ] Transition Report on Form 20-F<br>
[ ] Transition Report on Form 11-K<br>
[ ] Transition Report on Form 10-QSB<br>
[ ] Transition Report on Form N-SAR<br>
For the Transition Period Ended: </font></p>

<p><font SIZE="2">Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein. If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the notification relates:</font></p>

<p align="center"><b><font SIZE="2">PART I - REGISTRATION INFORMATION</font></b></p>

<table border="0" cellspacing="0" width="100%">
  <tr>
    <td width="100%" align="center" style="height: 1px"><font size="2">Emerald Medical Applications
	Corp.</font></td>
  </tr>
  <tr>
    <td width="100%" align="center" style="text-decoration: underline; height: 1px;">
<font SIZE="2">7 Imber Street, Petach Tivka, 4951141 Israel</font></td>
  </tr>
  <tr>
    <td width="100%" align="center" style="height: 1px"><font size="1">Address of&nbsp; Principal Executive Office
    (Street and Number)</font></td>
  </tr>
</table>
<b>

<p align="center"><font SIZE="2">PART II - RULE 12b-25(b)</font></p>
</b>

<p ALIGN="JUSTIFY"><font SIZE="2">If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">[X] (a) The reasons described in reasonable detail in
Part III of this form could not be eliminated without unreasonable effort or expense;</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">[X] (b) The subject annual report on Form 10-K will be
filed on or before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the prescribed due date.</font></p>
<b>

<p align="center"><font SIZE="2">PART III - NARRATIVE</font></p>
</b>

<p ALIGN="JUSTIFY"><font SIZE="2">The Registrant's quarterly report on Form 10-Q could not be
filed within the prescribed time period because the Registrant encountered delays in
preparing its financial statements.</font></p>
<b>

<p align="center"><font SIZE="2">PART IV - OTHER INFORMATION</font></p>
</b>

<p><font SIZE="2">(1) Name and telephone number of person to contact in regard to this
notification.</font></p>

<table border="0" cellspacing="0" width="100%">
  <tr>
    <td width="100%" align="center" style="text-decoration: underline; height: 1px;"><font SIZE="2">
	Alimi Ahmed, CEO</font></td>
  </tr>
  <tr>
    <td width="100%" align="center" style="height: 1px"><font size="1">(Name)</font></td>
  </tr>
  <tr>
    <td width="100%" align="center" style="text-decoration: underline; height: 1px;"><font SIZE="2">
	+(972) 3-744-4505</td>
  </tr>
  <tr>
    <td width="100%" align="center" style="height: 1px"><font size="1">(Area Code) (Telephone Number)</font></td>
  </tr>
</table>

<p ALIGN="JUSTIFY"><font SIZE="2">(2) Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no, identify
report(s).</font></p>

<p ALIGN="CENTER"><font SIZE="2">[<b>X</b>] Yes [ ] No</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">(3) Is it anticipated that any significant changes in
results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion
thereof?</font></p>

<p ALIGN="CENTER"><font SIZE="2">[&nbsp; ] Yes [<b>X</b>] No</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.</font></p>

<p ALIGN="center"><font SIZE="2">____________________________________________________</font></p>

<p align="center"><font size="1"><font size="2">
<u>Emerald Medical Applications
	Corp.</u><br></font>Name of Registrant as Specified in Charter</font></p>

<p><font SIZE="2">has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.</font></p>

<table border="0" cellpadding="0" width="100%" cellspacing="0">
  <tr>
    <td width="100%" style="height: 1px"><font SIZE="2">By: Alimi Ahmed, CEO</font></td>
  </tr>
  <tr>
    <td width="100%" style="height: 1px"><font SIZE="2">Date: August 14, 2017</font></td>
  </tr>
  <tr>
    <td width="100%" style="height: 1px"><font SIZE="2">By /s/ Alimi Ahmed</font></td>
  </tr>
</table>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
